Isotype and glycoform selection for antibody therapeutics.

Keyphrases

• Glycoform 100%
• Biologic Activity 100%
• Antibody Therapeutics 100%
• Fc Receptor 66%
• Immune Complex 66%
• Major Components 33%
• Innate Immune Response 33%
• Adaptive Immune Response 33%
• Glycosylation 33%
• IgG Fc 33%
• Human IgG 33%
• Cellular Mechanisms 33%
• Sequence Homology 33%
• Monoclonal Antibody 33%
• Catabolic 33%
• Biological Function 33%
• Serum IgG 33%
• Hostile Environment 33%
• Catabolism 33%
• Structure-function Relationship 33%
• Therapeutic Monoclonal Antibody 33%
• Binding Function 33%
• Fc Region 33%
• Normal Human Serum 33%
• FcRn 33%
• Neonatal Fc Receptor 33%
• C1q Binding 33%
• Antibody Repertoire 33%

Immunology and Microbiology

• Fc Receptor 100%
• Immune Complex 100%
• Isotype 100%
• Monoclonal Antibody 100%
• Therapeutic Antibodies 100%
• Complement Component C1q 100%
• Adaptive Immune System 50%
• Infectious Agent 50%
• Glycosylation 50%
• Normal Human 50%
• Sequence Homology 50%
• Serum (Blood) 50%
• Structure Activity Relation 50%
• Neonatal Fc Receptor 50%

Biochemistry, Genetics and Molecular Biology

• Antigen Antibody Complex 100%
• Monoclonal Antibody 100%
• Fc Receptor 100%
• Therapeutic Antibodies 100%
• Glycosylation 50%
• Infectious Agent 50%
• Normal Human 50%
• Sequence Homology 50%
• Serum (Blood) 50%
• Structure Activity Relation 50%
• Adaptive Immunity 50%
• Neonatal Fc Receptor 50%